Non-cirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and management.
СтатьяКлинические рекомендацииНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Shukla Akash, Rockey Don C, Kamath Patrick S, Kleiner David E, Singh Ankita, Vaidya Arun, Koshy Abraham, Goel Ashish, Dökmeci A Kadir, Meena Babulal, Philips Cyriac Abby, Sharma Chhagan Bihari, Payawal Diana A, Kim Dong Joon, Lo Gin-Ho, Han Guohong, Qureshi Huma, Wanless Ian R, Jia Jidong, Sollano Jose D, Al Mahtab Mamun, Muthiah Mark Dhinesh, Sonderup Mark W, Nahum Mendez Sanchez, Merican Mohamed Ismail Bin, Ormeci Necati, Kawada Norifumi, Reddy Rajender, Dhiman R K, Gani Rino, Hameed Saeed S, Harindranath Sidharth, Jafri Wasim, Qi Xiaolong, Chawla Yogesh Kumar, Furuichi Yoshihiro, Zheng Ming-Hua, Sarin Shiv Kumar
Аннотация
Since the Asian Pacific Association for the Study of the Liver (APASL) published guidelines on non-cirrhotic portal fibrosis/idiopathic portal hypertension in 2007, there has been a surge in new information, especially with the introduction of the term porto-sinusoidal vascular disorder (PSVD). Non-cirrhotic intra-hepatic causes of portal hypertension include disorders with a clearly identifiable etiology, such as schistosomiasis, as well as disorders with an unclear etiology such as non-cirrhotic portal fibrosis (NCPF), also termed idiopathic portal hypertension (IPH). This entity is being increasingly recognized as being associated with systemic disease and drug therapy, especially cancer therapy. An international working group with extensive expertise in portal hypertension was assigned with formulating consensus guidelines to clarify the definition, diagnosis, histological features, natural history, and management of NCPF/IPH, especially in the context of PSVD. The guidelines were prepared based on evidence from existing published literature. Whenever there was paucity of evidence, expert opinion was included after detailed deliberation. The goal of this manuscript, therefore, is to enhance the current understanding and help create global consensus on the issues surrounding NCPF/IPH.